Fujirebio Diagnostics Appoints Grady Barnes as Chief Scientif...( MALVERN Pa. March 23 /- Fujirebio Dia...),Health
Navigation Links
Fujirebio Diagnostics Appoints Grady Barnes as Chief Scientific Officer
Date:3/23/2009
MALVERN, Pa., March 23 /PRNewswire/ -- Fujirebio Diagnostics, Inc., the premier cancer diagnostics company and the industry leader in cancer biomarker assays, today announced the appointment of Grady Barnes, Ph.D. as Chief Scientific Officer. Dr. Barnes comes to Fujirebio Diagnostics with 25 years of diagnostics experience. He has held various positions at Abbott and Meridian Bioscience, most recently as Vice President of Research & Development at Meridian Bioscience.
As Chief Scientific Officer, Dr. Barnes will be responsible for all scientific affairs including research and development, product development, process engineering and clinical and regulatory affairs. He will also assist in the selection of new product candidates and licensing opportunities for Fujirebio Diagnostics products.
"Dr. Barnes' extensive experience in diagnostics will be vital to sustaining Fujirebio Diagnostics' growth," says Paul Touhey, President and CEO of Fujirebio Diagnostics. "His expertise will support the growth and acceptance of biomarker assays in ovarian cancer, such as HE4, and help Fujirebio Diagnostics identify additional promising biomarkers in oncology."
Barnes received a Bachelor of Arts degree in natural sciences from
About Fujirebio Diagnostics, Inc.
Fujirebio Diagnostics is the premier cancer diagnostics company and the industry leader in cancer biomarker assays. Fujirebio Diagnostics specializes in the clinical development, manufacturing and commercialization of in-vitro diagnostic products for the management of human disease states, with an emphasis in oncology. Fujirebio Diagnostics is one of the group companies of Miraca Holdings, Inc., in Japan, s
'/>"/>
| SOURCE JFK Communications, Inc. Copyright©2009 PR Newswire. All rights reserved |
Related medicine news :
1. Fujirebio Diagnostics and Roche Diagnostics Sign Agreement for New Ovarian Cancer Test
2. Fujirebio Diagnostics and Abbott Agree To Develop New Ovarian Cancer Test for Abbotts Architect(R) Analyzers
3. Quest Diagnostics to Speak at the Bear Stearns Healthcare Conference
4. Pathway Diagnostics Announces Commercial Availability of SensiTrop(TM) HIV Co-receptor Tropism Assay
5. Hypertension Diagnostics Announces Fiscal Year 2007 Results
6. Foundation Venture Capital Group, LLC Invests in Start Up Committed to Breast Cancer Diagnostics
7. Meretek Diagnostics and Otsuka America Pharmaceutical, Inc. Announce Completion of Merger
8. Siemens Medical Solutions Diagnostics Announces the Release of the Rapidlab 1200 Series Version 2.0 Software
9. Virginia G. Piper Charitable Trust and Flinn Foundation launch molecular diagnostics initiative
10. HealthShares(TM) Announces Changes to the HealthShares(TM) Diagnostics and Composite Indexes
11. Optherion Licenses Worldwide Rights to Develop Age-Related Macular Degeneration Diagnostics Based on Chromosome 10 Genetic Variations
Post Your Comments:
(Date:11/25/2009)... Nationwide Imaging Services, known ...ons for diagnostic imaging equipment, now offering...ing financing options, service and installation wi...Medical Technologies of California) , ...- Nationwide Imaging Services is proud to announce...
(Date:11/25/2009)...CLEMENS,Mich.,Nov.25/PRNewswire/--TwomoreH1N1vacci...rday,Dec.5,theMacombCountyHealthDepartmentannounce...ceatFreedomHillCountyParkinSterlingHeights. ,, ...ewillrunfrom9a.m.to3p.m.Thethimerosol-freeversiono...ilesupplieslast.Bothinjectableandnasalsprayimmuniz...
(Date:11/25/2009)... - Two signaling pathways essential to normal huma...al growth factor receptor (EGFR) pathways - intera...d metastasis, researchers from The University of T...v. 25 issue of Molecular Cell . , This newly ch...omponents known to correlate with invasive cancer ...
(Date:11/25/2009)...ease is available in French . , An innovati...University Health Centre researchers has passed it...w approach is an immunotherapy customized for each... Routy from the Research Institute of the MUHC in ... de Montral. "This is a vaccine made for the indiv...
(Date:11/25/2009)... offer waistline-friendly ways to enjoy festive fe... News) -- If you love the five-week holiday smorga...eady stressing about the added pounds you,ll have ...,s possible, say nutrition experts, to enjoy holid...as you do today. , It,s all about devising a s...
Breaking Medicine News(10 mins):Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 2Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 3Health News:Macomb County Health Department Schedules Two More H1N1 Flu Vaccine Clinics Dec. 3 and 5 2Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 2Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 3Health News:Tailor-made HIV/AIDS treatment closer to reality 2Health News:Holiday Eating Without the Guilt -- or the Pounds 2Health News:Holiday Eating Without the Guilt -- or the Pounds 3[0] Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) [0] Macomb County Health Department Schedules Two More H1N1 Flu Vaccine Clinics Dec. 3 and 5[0] Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis[0] Tailor-made HIV/AIDS treatment closer to reality[0] Holiday Eating Without the Guilt -- or the Pounds
...tudy on mice has shown that a synthetic derivative..., may help boost the odds of living longer.
...ler says that the compound derived from creosote i...e mice fed a normal diet and NDGA have so far been...
...due University researchers have found evidence tha...nt role in the ocean circulation patterns that tr...rica and Europe.
According to Matthew Hube... Emanuel that suggests there is an additional fact...
...CAGO, June 1 The specialty oriented professional m...clinical information, today introduced SearchMedi...ine that will prioritize search results by publica...the new search engine at Chicago's McCormick Place...
... ORLEANS, A new pair of studies compare step count...oderate physical activity and 2) a one-mile mark. ...e 54th American College of Sports Medicine (ACSM) ...y, funded by the Centers for Disease Control and P...
...awful lot of sexuality in Enrique Iglesias lyrics ...se .
The Spanish singer recently revealed ...ought about sex every two minutes.
When as... every two minutes. That sounds about right,' the ...
...the June 1 issue of the Journal of Clinical Invest...of Rochester Medical Center shows that a key infla...to parsing out damage after a stroke and other bra...a hallmark of the disease.
While many scie...
Other Medicine News:Health News:Common Desert Shrub may Increase Longevity 2Health News:Tropical Cyclones Play Important Role in Climate-control 2Health News:CMPMedica Adds Oncology Search Engine to SearchMedica.com 2Health News:Step-Based Guidelines in New Pair of Studies 2Health News:Brain Inflammation A Friend for Alzheimer's Patients 2Health News:Brain Inflammation A Friend for Alzheimer's Patients 3(Date:11/24/2009)...-ChindexInternational,Inc.,("Chindex")(Nasdaq: CHD...ealthcareproductsandservicesinthePeople,sRepublico...1stAnnualPiperJaffray,"Unplugged"HealthCareConfere...tel. , Managementiscurrentlyscheduledtopresen...n-onemeetingsthroughouttheday.Awebcast,ofthepresen...
(Date:11/24/2009)...all/--QuestDiagnosticsIncorporated(NYSE: DGX ),the...ionandservices,announcedthatitisscheduledtospeakat...YorkCity.ThepresentationisscheduledforWednesday,De...conference,thecompanywillreaffirmits2009guidancefo...eed18%ofrevenues,anddilutedearningspersharefromcon...
(Date:11/24/2009)...RNewswire/-- EisaiInc.andPfizerIncannouncedtodayt...dforreviewEisai,sNewDrugApplication(NDA)foroncedai...bletsforthetreatmentofmoderatetosevereAlzheimer,sd...gofdonepezilHClinanextendedrelease,matrix-typetabl...thedrug.TheNDAisbasedonahead-to-headclinicalstudyc...
Breaking Medicine Technology:Chindex International to Present at Piper Jaffray Health Care Conference 2Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3Volcano Corporation Presentation At Canaccord Adams Conference To Be Webcast 13452 1Volcano Corporation Presentation At Canaccord Adams Conference To Be Webcast 13452 2Novavax Reports Second Quarter 2009 Financial Results 13450 1Novavax Reports Second Quarter 2009 Financial Results 13450 2Novavax Reports Second Quarter 2009 Financial Results 13450 3Novavax Reports Second Quarter 2009 Financial Results 13450 4Novavax Reports Second Quarter 2009 Financial Results 13450 5Novavax Reports Second Quarter 2009 Financial Results 13450 6Novavax Reports Second Quarter 2009 Financial Results 13450 7Novavax Reports Second Quarter 2009 Financial Results 13450 8Novavax Reports Second Quarter 2009 Financial Results 13450 9More Than 100 Healthy Schools Honored by the Alliance for a Healthier Generation 53936 1More Than 100 Healthy Schools Honored by the Alliance for a Healthier Generation 53936 2More Than 100 Healthy Schools Honored by the Alliance for a Healthier Generation 53936 3More Than 100 Healthy Schools Honored by the Alliance for a Healthier Generation 53936 4More Than 100 Healthy Schools Honored by the Alliance for a Healthier Generation 53936 5...ceuticals (, http://www.addrenex.com ) has made t...l of identifying and developing as many new drug c...he fast-paced timeline they have set for drug disc...veloping two new drugs, Clonicel(R) for,attention ...pertension,over the past two years. A new drug app...
...CEUTICALS, INC. (Pink Sheets: VION) announced toda...utch-Belgian Cooperative Trial Group,for Hematolog...al of,laromustine (Cloretazine(R) (VNP40101M)) wit... aged 18-65 with previously untreated acute myelog...(MDS)., Alan Kessman, Chief Executive Officer, co...
Other Medicine Technology:Addrenex Pharmaceuticals' New Hires Further Company Goal to Identify New Drugs for Adrenergic Regulation 2Addrenex Pharmaceuticals' New Hires Further Company Goal to Identify New Drugs for Adrenergic Regulation 3Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy 2Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy 3| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |